SEPTInvestingStart Free

PACB 8-K: Secondary offering

Pacific Biosciences

Filed with the SEC on · accession 0001104659-26-125166

PACB filed a 8-K (current report) with the SEC on Nov 10, 2026. Pacific Biosciences entered into an at-the-market (ATM) sales agreement with Allen & Company to sell up to $100 million of its common stock from time to time. The stock moved -5.1% by the first close after the filing.

Summary of the filing

Pacific Biosciences entered into an at-the-market (ATM) sales agreement with Allen & Company to sell up to $100 million of its common stock from time to time. Allen will act as sales agent and receive up to 3.0% commission on gross proceeds.

For details, click here →How to read a 8-K →

Key details

Maximum aggregate sales proceeds under ATM program$100.0M
Agent commission rate (up to)percent 3
IssuerPacific Biosciences of California, Inc.
Sales agentAllen & Company LLC
Legal counselWilson Sonsini Goodrich & Rosati, Professional Corporation
General counsel and corporate secretaryBrett Atkins

How PACB stock reacted

Close before

$2.36

Nov 9, 2026

First close after

-5.08%

$2.24

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for PACB, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PACB?

Click here

Frequently asked questions

What did PACB file with the SEC on Nov 10, 2026?

PACB filed a 8-K (Secondary offering). Pacific Biosciences entered into an at-the-market (ATM) sales agreement with Allen & Company to sell up to $100 million of its common stock from time to time. Allen will act as sales agent and receive up to 3.0% commission on gross proceeds.

What does a secondary offering mean for PACB stock?

New shares dilute existing holders and are often sold at a discount to the market price.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did PACB stock react to this filing?

PACB closed at $2.36 before the filing and $2.24 on Nov 10, 2026 (-5.08%).

Other PACB SEC filings

Get alerts when PACB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
PACB overviewPACB analysisPACB newsLatest SEC filings